We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.74% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
INNOVATE Corp
VATE
$102M
| $118K | ﹤0.01% |
3,194
| – | – |
|
2127
Rhythm Pharmaceuticals
RYTM
$7.77B
| $117K | ﹤0.01% |
+10,131
| New | +$88.9K |
|
2128
CoreCivic
CXW
$3.35B
| $116K | ﹤0.01% |
+10,365
| New | +$101K |
|
|
AUY
2129
DELISTED
Yamana Gold, Inc.
AUY
| $116K | ﹤0.01% |
20,717
+2,776
| +15% | +$13.1K |
|
|
TELL
2130
DELISTED
Tellurian Inc.
TELL
| $112K | ﹤0.01% |
21,071
-68,575
| -76% | -$231K |
|
|
SMED
2131
DELISTED
Sharps Compliance Corp
SMED
| $111K | ﹤0.01% |
18,811
-73,163
| -80% | -$460K |
|
2132
NovaGold Resources
NG
$3.37B
| $110K | ﹤0.01% |
+14,260
| New | +$100K |
|
2133
Custom Truck One Source
CTOS
$2.42B
| $102K | ﹤0.01% |
12,128
-3,610
| -23% | -$29.2K |
|
2134
Dianthus Therapeutics
DNTH
$6.07B
| $102K | ﹤0.01% |
2,206
+689
| +45% | +$37.6K |
|
2135
Outlook Therapeutics
OTLK
$211M
| $102K | ﹤0.01% |
2,868
-650
| -18% | -$20.3K |
|
2136
AEye
LIDR
$61.8M
| $100K | ﹤0.01% |
+611
| New | +$70K |
|
2137
Lexicon Pharmaceuticals
LXRX
$1.08B
| $100K | ﹤0.01% |
47,677
-71,597
| -60% | -$198K |
|
|
GATO
2138
DELISTED
Gatos Silver, Inc.
GATO
| $100K | ﹤0.01% |
+23,261
| New | +$128K |
|
2139
Matrix Service
MTRX
$330M
| $98K | ﹤0.01% |
+11,917
| New | +$90K |
|
2140
Mayville Engineering Co
MEC
$574M
| $97K | ﹤0.01% |
+10,388
| New | +$118K |
|
|
CANO
2141
DELISTED
Cano Health, Inc.
CANO
| $97K | ﹤0.01% |
+153
| New | +$96.5K |
|
2142
Axogen
AXGN
$2.61B
| $95K | ﹤0.01% |
+11,983
| New | +$103K |
|
2143
Rigel Pharmaceuticals
RIGL
$785M
| $93K | ﹤0.01% |
3,111
-1,488
| -32% | -$40.3K |
|
|
ME
2144
DELISTED
23andMe Holding Co
ME
| $91K | ﹤0.01% |
+1,182
| New | +$108K |
|
2145
AquaBounty Technologies
AQB
$7.67M
| $89K | ﹤0.01% |
2,386
+796
| +50% | +$27.7K |
|
2146
BARK
BARK
$96.8M
| $88K | ﹤0.01% |
+1,194
| New | +$85K |
|
|
FRGI
2147
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $87K | ﹤0.01% |
11,605
-9,890
| -46% | -$94.6K |
|
2148
Spyre Therapeutics
SYRE
$9.06B
| $85K | ﹤0.01% |
+1,471
| New | +$124K |
|
|
ROVR
2149
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $85K | ﹤0.01% |
+14,784
| New | +$88.6K |
|
2150
Retractable Technologies
RVP
$20.3M
| $84K | ﹤0.01% |
17,623
-4,330
| -20% | -$22.5K |
|
Similar funds
VGA
AQR Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
- AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.